Clarity Pharmaceuticals' market value is the price at which a share of Clarity Pharmaceuticals trades on a public exchange. It measures the collective expectations of Clarity Pharmaceuticals investors about its performance. Clarity Pharmaceuticals is trading at 3.00 as of the 14th of December 2024. This is a 3.54 percent decrease since the beginning of the trading day. The stock's lowest day price was 3.0. With this module, you can estimate the performance of a buy and hold strategy of Clarity Pharmaceuticals and determine expected loss or profit from investing in Clarity Pharmaceuticals over a given investment horizon. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Symbol
Clarity
Clarity Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Clarity Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Clarity Pharmaceuticals.
0.00
11/20/2023
No Change 0.00
0.0
In 1 year and 26 days
12/14/2024
0.00
If you would invest 0.00 in Clarity Pharmaceuticals on November 20, 2023 and sell it all today you would earn a total of 0.00 from holding Clarity Pharmaceuticals or generate 0.0% return on investment in Clarity Pharmaceuticals over 390 days.
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Clarity Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Clarity Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Clarity Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Clarity Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Clarity Pharmaceuticals historical prices to predict the future Clarity Pharmaceuticals' volatility.
Clarity Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12% return per unit of standard deviation over the last 3 months. Clarity Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Clarity Pharmaceuticals' mean deviation of 4.22, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0826, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Clarity Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Clarity Pharmaceuticals is likely to outperform the market. At this point, Clarity Pharmaceuticals has a negative expected return of -0.7%. Please make sure to confirm Clarity Pharmaceuticals' total risk alpha, and the relationship between the standard deviation and kurtosis , to decide if Clarity Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation
0.23
Weak predictability
Clarity Pharmaceuticals has weak predictability. Overlapping area represents the amount of predictability between Clarity Pharmaceuticals time series from 20th of November 2023 to 2nd of June 2024 and 2nd of June 2024 to 14th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Clarity Pharmaceuticals price movement. The serial correlation of 0.23 indicates that over 23.0% of current Clarity Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient
0.23
Spearman Rank Test
0.35
Residual Average
0.0
Price Variance
0.57
Clarity Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Clarity Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Clarity Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Clarity Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Clarity Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Clarity Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Clarity Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Clarity Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Clarity Pharmaceuticals pink sheet over time.
Current vs Lagged Prices
Timeline
Clarity Pharmaceuticals Lagged Returns
When evaluating Clarity Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Clarity Pharmaceuticals pink sheet have on its future price. Clarity Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Clarity Pharmaceuticals autocorrelation shows the relationship between Clarity Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Clarity Pharmaceuticals.